EUVIMEDEUVIMED entdecken
Crossref

Testing and Estimation of Treatment Effects in Clinical Trials for Terminal and Nonterminal Events Subject to Competing Risks

Song Yang iD

Statistics in Medicine · 2025

DOI: 10.1002/sim.70205 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Statistics in Medicine, 2025. Verfasst von Song Yang. Beteiligte Einrichtung: Office of Biostatistics Research, National Heart, Lung, and Blood Institute, Bethesda, Maryland, USA. Hauptthemen laut MEDLINE: Clinical Trials as Topic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In clinical trials, multiple outcomes are often of interest. For time‐to‐event outcomes, it is the norm rather than exception that one or more nonterminal events (e.g., heart failure hospitalization) and a terminal event (e.g., cardiovascular death) are encountered, subject to competing risks in addition to independent censoring. In this setting, traditionally, time‐to‐first event analysis is used to assess treatment effect, with popular procedures such as the log‐rank test and the Cox proportional hazards regression. However, this approach fails to fully utilize available data, resulting in relatively wide confidence intervals and less powerful tests. Various methods have been proposed in recent years, some involving complex models and others having intuitive appeal but hidden conditions. Furthermore, each method was motivated to address specific scientific questions. Navigating this landscape can be challenging for users. In addition, although competing risks can often be accommodated by considering cause‐specific hazards, that is not the case for some of the recently proposed methods, which may lead to difficulty in interpretation, requirement of strong assumptions, and less generalizability. This article provides a brief summary of several recently developed methods, discussing the strengths and limitations of each approach. Then, the problem is framed in a more general setup than in the literature for a wider range of competing risks scenarios. Furthermore, new nonparametric testing and estimation procedures are proposed, and their asymptotic validity is established. The methods are illustrated in a recent large scale clinical trial.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clinical Trials as TopicHumansProportional Hazards ModelsTreatment OutcomeModels, StatisticalComputer SimulationData Interpretation, StatisticalRisk Assessment

Stichwörter der Autor:innen

competing riskssemi‐ and non‐parametric inferencesurvival analysisterminal and nonterminal eventstreatment effect

Autor:innen und Institutionen

  • Office of Biostatistics Research, National Heart, Lung, and Blood Institute, Bethesda, Maryland, USA.

ORCID-Profile: Song Yang

Zitieren

APA

Yang, S. (2025). Testing and Estimation of Treatment Effects in Clinical Trials for Terminal and Nonterminal Events Subject to Competing Risks. Statistics in Medicine. https://doi.org/10.1002/sim.70205

Vancouver

Yang S. Testing and Estimation of Treatment Effects in Clinical Trials for Terminal and Nonterminal Events Subject to Competing Risks. Statistics in Medicine. 2025. doi:10.1002/sim.70205

BibTeX
@article{Yang2025,
  author = {Yang, Song},
  title = {Testing and Estimation of Treatment Effects in Clinical Trials for Terminal and Nonterminal Events Subject to Competing Risks},
  journal = {Statistics in Medicine},
  year = {2025},
  doi = {10.1002/sim.70205}
}
Kostenlos starten →